Prostate Cancer, PSA, and Questions That Can Only Be Answered by Clinical TrialsWard, John F.Oncology (08909091)
{eng}, number = {8}, pages = {410--411}, publisher = {Nature Publishing Group}, series = {Nature Clinical Practice Urology}, title = {Can PSA velocity predict risk of death in men with prostate cancer?}, url = {http://dx.doi.org/10.1038/ncpuro0811}, volume = {4}, year = {...
prostate cancerPSAradiotherapyPubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites....
cancerworld.net (全网免费下载) cancerworld.org (全网免费下载) cancerworld.org (全网免费下载) cancerworld.org 相似文献Defining and Treating High-Risk Prostate Cancer: Can We Do Better? Background: Prostate cancer (PCa) patients with pretreatment prostate-specific antigen (PSA) >20 ng/ml have a...
Can stage 4 testicular cancer be cured? Can testicular cancer be cured without surgery? Can colon cancer spread to the prostate? Is prostate cancer a hereditary disease? Can a man have intercourse after prostate cancer? Can an ultrasound detect prostate cancer?
With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic t
began hormonal therapies and everything else, was able to predict how well patients were going to respond to the treatment, how long they would be responding to the treatment and how long overall they would be living with immediate overall survival with various treatments for prostate cancer. So...
Int J Radiat Oncol Biol Phys 64: 1140-1150 Synopsis Background A number of studies have linked prostate-specific antigen (PSA) nadir and time to PSA nadir (TnPSA) with outcomes following radiotherapy for prostate cancer. Could these factors be used to identify high-risk patients eligible for ...
( 2006 ) Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability . J Natl Cancer Inst 98 : 1521 – 1527 Serum PSA values >4.0 ng/ml are routinely used to select patients for prostate biopsy, although this approach misses some early-...
With increasing incidence and geography, cancer is one of the leading causes of death, reduced quality of life and disability worldwide. Principal progress in the development of new anticancer therapies, in improving the efficiency of immunotherapeutic t